Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Zookeys ; 1193: 49-61, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38455092

RESUMEN

A new genus and species of Encyrtidae (Hymenoptera: Chalcidoidea), Apteronotus Kang, Hu & Luo, gen. nov. (type species A.indigus Kang, Hu & Luo, sp. nov.), associated with insects inhabiting Oxytropis spp., and three newly recorded species for China, Copidosomaclavatum, Ericydnusaeneus and Tetracnemuskozlovi, are described from the Altun Mountain Nature Reserve, Xinjiang. Detailed illustrations of all species were included to support the identification and further study.

2.
Int Immunopharmacol ; 131: 111862, 2024 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-38513574

RESUMEN

Astragaloside IV(ASⅣ), the main component of Radix Astragali, has been used to treat cerebral ischemia reperfusion injury (CIRI). However, the molecular mechanism of ASIV in CIRI needs to be further elucidated. Long non-coding RNA (lncRNA) is considered to be an important kind of regulatory molecule in CIRI. In this work, the biological effect and molecular mechanism of ASIV in CIRI through lncRNA were analyzed by using rat middle cerebral artery occlusion and reperfusion (MCAO/R) model and primary rat microglia (RM) cells oxygen and glucose deprivation/reoxygenation (OGD/R) model. The neurological deficit score was evaluated, the volume of cerebral infarction was calculated, and pyroptosis related molecules were detected by qPCR and western blot. Then, high-throughput sequencing was performed in sham and MCAO/R groups. The competitive endogenous RNA (ceRNA) networks associated with pyroptosis were constructed by functional enrichment analysis. CCK-8 detection of cell survival rate, qPCR and western blot were used to determine the specific molecular mechanism of ASⅣ through ceRNA in vitro. Results showed thatASⅣ could decrease the neurological deficit score, reduce the volume of cerebral infarction, inhibit inflammatory reaction and pyroptosis in MCAO/R model rats. Next, the ceRNA network was established, including the LOC102555978/miR-3584-5p/NLRP3 regulatory network. In vitro experiments showed that LOC102555978 promotes NLRP3 mediated pyroptosis of RM cells through sponge adsorption of miR-3584-5p, which may provide a potential therapeutic target for post-CIRI inflammation regulation. ASⅣ could inhibit pyroptosis of RM cells by down-regulating LOC102555978. LOC102555978/miR-3584-5p/NLRP3 may be the molecular mechanism of ASⅣ's CIRI protective effect.


Asunto(s)
Isquemia Encefálica , MicroARNs , ARN Largo no Codificante , Daño por Reperfusión , Saponinas , Triterpenos , Ratas , Animales , Piroptosis , Proteína con Dominio Pirina 3 de la Familia NLR/genética , ARN Largo no Codificante/genética , ARN Largo no Codificante/uso terapéutico , Microglía , Isquemia Encefálica/genética , Reperfusión , Infarto de la Arteria Cerebral Media/complicaciones , Daño por Reperfusión/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA